Shattuck Labs (STTK) Total Current Liabilities (2019 - 2026)
Shattuck Labs (STTK) reported Total Current Liabilities of $4.2 million for Q1 2026, down 41.91% year-over-year from $7.3 million in Q1 2025, and down 39.75% quarter-over-quarter from $7.1 million in Q4 2025.
Shattuck Labs (STTK) Total Current Liabilities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Total Current Liabilities data on file, last reported at $4.2 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $4.2 million, down 41.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 41.91% YoY), and the FY2025 annual result was $7.1 million, down 20.92% from the prior year.
- Total Current Liabilities slipped to $4.2 million in Q1 2026 per STTK's latest filing, from $7.1 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $25.0 million in Q4 2022 and troughed at $4.2 million in Q1 2026.
- A 5-year average of $12.9 million and a median of $13.0 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 60.45% in 2022, then slumped 64.49% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $25.0 million in 2022, then plunged by 54.12% to $11.5 million in 2023, then dropped by 22.14% to $8.9 million in 2024, then declined by 20.92% to $7.1 million in 2025, then plunged by 39.75% to $4.2 million in 2026.
- Business Quant data shows STTK's Total Current Liabilities at $4.2 million in Q1 2026, $7.1 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 4.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.25 Mn |
| Dec 31, 2025 | 7.05 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.34 Mn |
| Mar 31, 2025 | 7.32 Mn |
| Dec 31, 2024 | 8.92 Mn |
| Sep 30, 2024 | 12.40 Mn |
| Jun 30, 2024 | 15.03 Mn |
| Mar 31, 2024 | 14.33 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Sep 30, 2023 | 14.06 Mn |
| Jun 30, 2023 | 12.99 Mn |
| Mar 31, 2023 | 16.01 Mn |
| Dec 31, 2022 | 24.97 Mn |
| Sep 30, 2022 | 19.14 Mn |
| Jun 30, 2022 | 24.25 Mn |
| Mar 31, 2022 | 16.81 Mn |
| Dec 31, 2021 | 24.59 Mn |
| Sep 30, 2021 | 19.84 Mn |
| Jun 30, 2021 | 15.11 Mn |